Skip to main content
. 2020 Mar 13;57(12):829–834. doi: 10.1136/jmedgenet-2019-106759

Figure 1.

Figure 1

Overview of the CanVIG-UK membership profile (survey of CanVIG-UK members, performed on 29 October 2019, return rate 83/103 (81%). HBOC, hereditary breast and ovarian cancer; MMR, mismatch repair. CanVIG-UK, Cancer Variant Interpretation Group UK.